Omland Turid, Lie Kathrine A, Akre Harriet, Sandlie Lars Erik, Jebsen Peter, Sandvik Leiv, Nymoen Dag Andre, Bzhalava Davit, Dillner Joakim, Brøndbo Kjell
Department of Otorhinolaryngology/Head and Neck Surgery, Oslo University Hospital and University of Oslo, Institute of Clinical Medicine, Oslo, Norway.
Department of Pathology, Oslo University Hospital, Oslo, Norway.
PLoS One. 2014 Jun 11;9(6):e99114. doi: 10.1371/journal.pone.0099114. eCollection 2014.
Patients with recurrent respiratory papillomatosis (RRP) in Norway treated between 1987 and 2009 were recruited to this cohort study. They were followed from disease onset and data recorded until January 2012. Here, we describe the distribution of human papillomavirus (HPV) genotypes, the prevalence of multiple HPV infections, and the risk of high-grade laryngeal neoplasia and respiratory tract invasive carcinoma in a large cohort of patients with RRP. We also examined whether HPV genotype, gender, age or clinical course are risk factors for this development. Clinical records and histological specimens were reviewed. Using formalin-fixed paraffin-embedded biopsies, HPV genotyping were performed by quantitative polymerase chain reaction assays identifying 15 HPV types. HPV-negative specimens were analyzed by metagenomic sequencing. Paraffin blocks were available in 224/238 patients. The DNA quality was approved in 221/224 cases. HPV DNA was detected in 207/221 patients and all were HPV 6 or HPV 11 positive, comprising HPV 6 in 133/207, HPV 11 in 40/207 cases and HPV 6/11 in 15/207 cases. Co-infection with one or two high-risk HPV types together with HPV 6 or HPV 11 was present in 19/207 patients. Metagenomic sequencing of 14 HPV-negative specimens revealed HPV 8 in one case. In total, 39/221 patients developed high-grade laryngeal neoplasia. 8/221 patients developed carcinoma of the respiratory tract (six patients with laryngeal carcinoma and two patients with lung carcinoma). High-grade laryngeal neoplasias were found more frequently in HPV-negative versus HPV-positive patients, (RR = 2.35, 95% CI 1.1, 4.99), as well as respiratory tract carcinomas (RR = 48, 95% CI 10.72, 214.91). In summary, the majority of RRP were associated with HPV 6 and/or 11. HPV-negative RRP biopsies occurred more frequently in adult-onset patients, and were associated with an increased risk of laryngeal neoplasia and carcinoma in the respiratory tract.
1987年至2009年期间在挪威接受治疗的复发性呼吸道乳头状瘤病(RRP)患者被纳入了这项队列研究。从疾病发作开始对他们进行随访,并记录数据直至2012年1月。在此,我们描述了一大群RRP患者中人乳头瘤病毒(HPV)基因型的分布、多重HPV感染的患病率以及高级别喉肿瘤和呼吸道浸润性癌的风险。我们还研究了HPV基因型、性别、年龄或临床病程是否为此类病变的危险因素。对临床记录和组织学标本进行了回顾。使用福尔马林固定石蜡包埋活检标本,通过定量聚合酶链反应分析进行HPV基因分型,确定了15种HPV类型。对HPV阴性标本进行宏基因组测序。238例患者中有224例有石蜡块。224例中有221例的DNA质量合格。221例患者中检测到HPV DNA,所有患者均为HPV 6或HPV 11阳性,其中133/207例为HPV 6,40/207例为HPV 11,15/207例为HPV 6/11。207例患者中有19例同时感染一种或两种高危HPV类型以及HPV 6或HPV 11。对14例HPV阴性标本进行宏基因组测序,1例检测到HPV 8。221例患者中共有39例发生高级别喉肿瘤。221例患者中有8例发生呼吸道癌(6例喉癌和2例肺癌)。HPV阴性患者中高级别喉肿瘤的发生频率高于HPV阳性患者(RR = 2.35,95% CI 1.1,4.99),呼吸道癌也是如此(RR = 48,95% CI 10.72,214.91)。总之,大多数RRP与HPV 6和/或11相关。HPV阴性的RRP活检在成人发病患者中更常见,并且与喉肿瘤和呼吸道癌风险增加相关。